| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/08/2008 | US7396915 Specifically recognizing cancer cells such as non-small cell lung cancer, pancreatic cancer and gastric cancer cells; diagnosis and therapy |
| 07/08/2008 | US7396914 SARS nucleic acids, proteins, antibodies, and uses thereof |
| 07/08/2008 | US7396913 Erythropoietin receptor binding antibodies |
| 07/08/2008 | US7396911 Preventing, treating, or ameliorating human immunodeficiency virus infection |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396907 Antibodies that bind PRO6182 polypeptides |
| 07/08/2008 | US7396906 Pro4399 Polypeptides |
| 07/08/2008 | US7396904 Tumor-associated peptides binding to MHC-molecules |
| 07/08/2008 | US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396661 Expressing Fab/immunoglobulin fragments in bacterial cells; diagnosis and treatment of diabetes, multiple sclerosis and rheumatoid arthritis |
| 07/08/2008 | US7396652 Chemokine PANEC-2 polypeptides and compositions and methods related thereto |
| 07/08/2008 | US7396533 Polypeptides and nucleic acids encoding same |
| 07/08/2008 | US7396530 by integrin (anti-CD11a antibody/efalizumab) antagonist; synergistic with cyclosporine, isotretinoin, etretinate, corticosteroids, fumaric acid esters, dapsone, niacinamide, low-dose chlorambucil, clofazimine or immunosuppressive agent; side effect reduction, rapid improvement |
| 07/08/2008 | CA2250712C Chimeric isoprenoid synthases and uses thereof |
| 07/08/2008 | CA2218884C Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 07/08/2008 | CA2198706C Methods for the treatment of inflammatory joint disease |
| 07/08/2008 | CA2188029C Porphocyanine and cnc-expanded porphyrins |
| 07/08/2008 | CA2150262C Multivalent and multispecific binding proteins, their manufacture and use |
| 07/08/2008 | CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/08/2008 | CA2117782C Use of renin-angiotensin antagonist for reducing post myocardial infarct morbidity and mortality |
| 07/08/2008 | CA1341576C Diagnosis of retinoblastoma |
| 07/03/2008 | WO2008080045A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 07/03/2008 | WO2008080014A2 Antifungal plant proteins and methods of their use |
| 07/03/2008 | WO2008079995A2 Conjugate of natriuretic peptide and antibody constant region |
| 07/03/2008 | WO2008079890A1 Hepatitis c virus (hcv) inhibitory monoclonal antibody and bindable ligand thereof |
| 07/03/2008 | WO2008079849A2 Antibodies to insulin-like growth factor receptor |
| 07/03/2008 | WO2008079466A1 Antibodies and methods for making and using them |
| 07/03/2008 | WO2008079359A2 Human antibodies that bind human il-12 and methods for producing |
| 07/03/2008 | WO2008079352A2 Antibodies to cd200r |
| 07/03/2008 | WO2008078715A1 Therapeutic agent for inflammatory myopathy containing il-6 antagonist as active ingredient |
| 07/03/2008 | WO2008078179A1 Trkb agonists for treating autoimmune disorders |
| 07/03/2008 | WO2008078177A2 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence |
| 07/03/2008 | WO2008077945A2 Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies |
| 07/03/2008 | WO2008077889A1 Analytical method for analyzing c-terminus truncation |
| 07/03/2008 | WO2008077547A1 Shrna-mediated inhibition of expression of alpha-1. 6-fucosyltransferase |
| 07/03/2008 | WO2008077546A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 07/03/2008 | WO2008077545A1 Selection method |
| 07/03/2008 | WO2008077356A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia |
| 07/03/2008 | WO2008077355A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 07/03/2008 | WO2008077171A1 Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 07/03/2008 | WO2008054603A9 Il-17 receptor a antigen binding proteins |
| 07/03/2008 | WO2008054603A2 Il-17 receptor a antigen binding proteins |
| 07/03/2008 | WO2008051977A3 Methods of reducing phosphate absorption |
| 07/03/2008 | WO2008049920A3 Il-21 variants |
| 07/03/2008 | WO2008027162A3 129xe biosensors and their use |
| 07/03/2008 | WO2008021156A3 Antibodies to il-17a |
| 07/03/2008 | WO2008017859A3 Ligand for the g6b receptor on blood platelets |
| 07/03/2008 | WO2008015218A3 Method for diagnosis of a disease involving an anti-at1-receptor antibody |
| 07/03/2008 | WO2008014386A3 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists |
| 07/03/2008 | WO2007147165A3 Human cancer stem cell culture compositions comprising erbb2 variants and methods of use thereof |
| 07/03/2008 | WO2007140410A3 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 07/03/2008 | US20080163387 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/03/2008 | US20080161542 Bridgehead Labelled Compounds and Methods of Using the Same |
| 07/03/2008 | US20080161541 Fc Variants with Increased Affinity for FcyRIIc |
| 07/03/2008 | US20080161540 IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| 07/03/2008 | US20080161537 Selective radiolabeling of biomolecules |
| 07/03/2008 | US20080161424 Compositions and Methods for the Systemic Treatment of Arthritis |
| 07/03/2008 | US20080161262 Using oligonucleotide sequences specific to interleukin beta as blocking agents for treatment and prevention of juvenile idiopathic arthritis |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161238 Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance |
| 07/03/2008 | US20080161230 Methods and Kits for Stabilising, Protecting and Solubilising Proteins |
| 07/03/2008 | US20080161226 Activatable Clostridial Toxins |
| 07/03/2008 | US20080160636 Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160595 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides |
| 07/03/2008 | US20080160582 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160571 Antibodies that bind TNF-alpha converting enzyme |
| 07/03/2008 | US20080160540 Polypeptides Related to Natriuretic Peptides and Methods of Their Identification and Use |
| 07/03/2008 | US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160037 Novel beta-defensins |
| 07/03/2008 | US20080160035 Cytokine specific immunoglobulin for use in diagnosis, prevention and treatment ,of cell proliferative, inflammatory, allergic, respiratory, autoimmune and arthritic disorders |
| 07/03/2008 | US20080160034 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 07/03/2008 | US20080160032 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis |
| 07/03/2008 | US20080160030 Anti-Interferon Alpha Monoclonal Antibodies and Methods for Use |
| 07/03/2008 | US20080160029 Treatment with anti-vegf antibodies |
| 07/03/2008 | US20080160027 Chlamydia pneumoniae vaccine and methods for administering such a vaccine |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160020 Methods For Reducing the Symptoms of Autoimmunity and Inflammation Using Binding Proteins Against Antigens Exposed on Dead or Dying Cells |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160017 Cross-Linked Antibodies |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080160015 Monoclonal antibody for use in treatment of hemophila |
| 07/03/2008 | US20080160012 Using transmembrane protein with EGF-like and 2 follistatin-like domains 2 (TMEFF2) specific immunogllobulin for use in diagnosis, prevention and treatment prostate cancer |
| 07/03/2008 | US20080160010 Peptide That Elicits Neutralizing Antibodies Targeting the Hiv Co-Receptor |
| 07/03/2008 | US20080160009 Antibodies; calcium channel modulators (mibefradil); apoptosis resistance |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080159992 membrane polypeptide for use in designing therapeutic for use treatment and prevention of cell proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | US20080159981 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 07/03/2008 | CA2832111A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2676188A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of the b-chronic lymphocytic leukemia |
| 07/03/2008 | CA2676185A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 07/03/2008 | CA2673725A1 Antibodies and methods for making and using them |
| 07/03/2008 | CA2673639A1 Human antibodies that bind human il-12 and methods for producing |
| 07/03/2008 | CA2673525A1 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 07/03/2008 | CA2673282A1 Antibodies to cd200r |